ArticleMolecular therapy. Oncology2026

Feasibility and outcomes of decentralized point-of-care CD19 CAR T cell for relapsed large B cell lymphoma in resource-limited settings.

Koramit Suppipat et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.